Search
                    Heart Failure, Congestive Clinical Trials
A listing of 4  Heart Failure, Congestive  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 4 of 4
        
        
    
                There are currently 4 active clinical trials seeking participants for Heart Failure, Congestive research studies. The states with the highest number of trials for Heart Failure, Congestive participants are California, Florida, New York and Pennsylvania.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Dilated Cardiomyopathy (DCM) Research Study
            
        Recruiting
            
        If you are identified as eligible for investigational genetic testing, you will be sent a saliva collection kit to your home. Once you have completed and returned your kit to Sano Genetics, your sample will be tested for a specific genetic pathway called BAG3.
Investigational genetic testing can help you better understand your body and its needs, as well as how DCM may be passed down in your family. Those who are identified as having a variant in the BAG3 gene will be referred to an upcoming clinical trial.
    Investigational genetic testing can help you better understand your body and its needs, as well as how DCM may be passed down in your family. Those who are identified as having a variant in the BAG3 gene will be referred to an upcoming clinical trial.
                            Conditions: 
                                    
        
            
                        Dilated Cardiomyopathy (DCM)
                    
                                    
                        Cardiovascular Diseases
                    
                                    
                        Cardiomyopathy
                    
                                    
                        Cardiovascular Disease
                    
                                    
                        Heart Failure
                    
                                    Featured Trial
                
                Heart failure clinical study is now enrolling
            
        Recruiting
            
        Are you interested in a clinical study exploring an investigational medicine for heart failure, also known as HF? The MARITIME-HF clinical study is testing an investigational medicine to see if it can reduce HF-related symptoms and risk of hospitalization in people living with HF and obesity.
Researchers are focused on developing a potential option for reducing HF-related symptoms. By participating, you may contribute to research that may offer benefits for those in the future in need of a different way to manage their HF.
Answer just a few questions to submit your information and see if you may qualify
    Researchers are focused on developing a potential option for reducing HF-related symptoms. By participating, you may contribute to research that may offer benefits for those in the future in need of a different way to manage their HF.
Answer just a few questions to submit your information and see if you may qualify
                            Conditions: 
                                    
        
            
                        Heart Failure
                    
                                    
                        Congestive Heart Failure
                    
                                    
                        Chronic Heart Failure
                    
                                    
                        Heart Failure
                    
                                    
                        Congestive
                    
                                    
                
                                    Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
                                
            
            
        Recruiting
                            
            
                Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy.
Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.             
        
        
    Gender:
                ALL
            Ages:
                21 years and above
            Trial Updated:
                07/28/2025
            
            Locations: Birmingham VA Health Care System, Birmingham, Alabama  +46 locations         
        
        
            Conditions: Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; With Decompensation, Heart Failure, Congestive
        
            
        
    
                
                                    Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
                                
            
            
        Recruiting
                            
            
                The metabolism of the heart provides the chemical energy needed to fuel ongoing normal heart contraction. Magnetic resonance spectroscopy is a technique used in a MRI scanner that can be used to measure and study heart metabolism directly but without blood sampling or obtaining tissue biopsies. One of the hypotheses this study aims to investigate is whether energy metabolism is reduced in heart failure and whether that contributes to the poor heart function.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                07/09/2025
            
            Locations: Johns Hopkins Medical Institutions, Baltimore, Maryland         
        
        
            Conditions: Heart Failure, Congestive
        
            
        
    
                
                                    Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
                                
            
            
        Recruiting
                            
            
                The overall hypothesis of this study is that subtle interactions between structural (substrate) and functional (trigger) abnormalities of the heart, some of which are genetically-determined, can be used to identify patients at high risk of sudden cardiac death (SCD). Such information may be used to better define patients most likely to benefit from replacement of an internal defibrillator (ICD). The prospective, observational study to enroll, categorize and follow patients who receive an ICD pul...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 85 years
            Trial Updated:
                01/10/2025
            
            Locations: Washington Hospital Center, Washington, District of Columbia  +3 locations         
        
        
            Conditions: Heart Failure, Congestive, Death, Sudden, Cardiac, Arrhythmia, Cardiomyopathies
        
            
        
    
                
                                    Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
                                
            
            
        Recruiting
                            
            
                The DART-HA study is a single-center, open label, trial intended to evaluate the clinical efficacy of standard treatment options for congestive heart failure (observation, diuretic or afterload reduction therapy) in patients without new symptoms who have developed abnormalities of the HeartLogic heart failure diagnostic feature.             
        
        
    Gender:
                ALL
            Ages:
                19 years and above
            Trial Updated:
                01/25/2024
            
            Locations: Heart Center Research, LLC, Huntsville, Alabama         
        
        
            Conditions: Heart Failure, Congestive
        
            
        
    1 - 4 of 4
            
            
        